QbCheck

Objective measurement of ADHD symptoms

• Quantifies inattention, impulsivity and motor activity.

• Uses motion tracking with 1 mm accuracy, through facial recognition technology.

• Results benchmarked against age and sex-matched norm groups and ADHD clinical groups.

Remote or in-clinic flexibility

• Fully web based.

• Can be completed at home for patients on a waitlist or at risk, school, workplace or clinic.

• Supports digital-first and hybrid ADHD models.

• Used across CAHMS, Community Paediatrics and Adult services.

Clinician workflow integration (via QbClinic)

• Patient management, multi-site clinic support, test tracking.

• Auto generated structured reports.

• Ability to assign QbCheck + subjective rating scale as one integrated task list.

• Admin efficiency features e.g. Patient reminder emails and clinician notified once task are completed. This feature can help increase completion rate of pre-assessment information so that the clinician has necessary information completed prior to clinic and prevent the clinician/admin team needing to follow up patients.

Supports diagnosis, treatment optimisation & monitoring

• QbCheck can be completed in the patient’s home setting. This enables services to choose whether to invite patients into clinic or to free up clinic space and clinician time to gather objective data on core symptoms as part of pre-assessment remotely.

• The QbCheck report (adjunct with other clinical information) can be used to prioritise patients who are most at risk.

• Used in diagnostic pathways as objective evidence to complement interviews and rating scales.

• QbCheck can be used in a pathway to add objective data to the pre-assessment information. Improving waiting list and risk management and potentially freeing up clinic space.

• Also used in medication titration to monitor response and optimise treatment.

QbCheck has completed all required approvals:

• MDR + UKCA regulated medical device

• ISO 13485 & ISO 27001 accredited

• Registered on MHRA PARD

• Fully compliant with NHS IG requirements including DPIA, DTAC and cyber security

QbCheck is straightforward to add onto existing QbTest agreements. NHS test fee prices are available, valid for 12 months, with automatic renewal when credits run out. Purchase for tests can be charged monthly in arrears (like QbTest contract) or annual upfront, we can accommodate budget processes to enable a compliant procurement process.

Evidence Base

• Strong NICE endorsed evidence exists for QbTest (predecessor and lab based version).

• QbCheck is equivalent to QbTest and the test construct is identical.

• QbCheck reliability, validity and clinical utility studies already published and widely used internationally.

• Head-to-head comparison studies to demonstrate that QbCheck completed in the home setting is highly convergent with sensitivity and specificity of QbTest completed in clinic.

• Over 10,000 clinicians currently use Qbtech products.

• Qbtech technology is used in 75% of NHS trusts already and many NHS trusts are adding QbCheck to their ADHD pathway to further improve their service.

Pathway Impact

• Qbtech Clinical Advisor team support pathway mapping and implementation of QbCheck to ensure that the technology adds maximum value for the NHS.

• QbCheck can be completed at home, helping to reach those waiting, freeing up in-clinic resources.

• Narrative evidence of significant capacity gains.

• Reduced clinician admin burden.

• Enables earlier determination of “diagnostic complexity,” reducing time spent in clinic on unsuitable referrals.

• QbCheck is easily integrated into clinical workflow management.

• Implementation and Clinical Advisor teams support onboarding; structured training and clinical guidance available.

QbCheck supports equitable access by:

• Allowing remote completion, minimising travel barriers and supporting those unable to attend clinic.

• Patients diagnosed with ADHD and neurodevelopmental conditions have been involved in the user interface to help ensure the instructions and flow is as easy to understand and engage with as possible to help improve accessibility. WCAG compliance.

• Providing an objective, standardised ADHD measurement tool that reduces clinician variation and potential bias.


Qbtech is actively collaborating with lived experience panels and the national ADHD Taskforce to refine user experience. Qbtech technology is the first and only to be added to NICE diagnostic guidance and as a recommendation in the NHS ADHD Taskforce report.